Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen

NCT04346615 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
47
Enrollment
INDUSTRY
Sponsor class

Stopped Lack of enrollment due to evolution of COVID-19 pandemic with reduction in patients at risk for severe disease and growing number of effective alternative therapies

Conditions

Interventions

Sponsor

Pfizer